147 related articles for article (PubMed ID: 36308713)
21. Characterization of Plasmacytoid Dendritic Cells, Microbial Sequences, and Identification of a Candidate Public T-Cell Clone in Kikuchi-Fujimoto Disease.
Nelson ND; Meng W; Rosenfeld AM; Bullman S; Sekhar Pedamallu C; Nomburg JL; Wertheim GB; Paessler ME; Pinkus G; Hornick JL; Meyerson M; Luning Prak ET; Pillai V
Pediatr Dev Pathol; 2021; 24(3):193-205. PubMed ID: 33530869
[TBL] [Abstract][Full Text] [Related]
22. Kikuchi-Fujimoto disease as a rare cause of lymphadenopathy--two cases report and review of current literature.
Mrówka-Kata K; Kata D; Kyrcz-Krzemień S; Sowa P
Otolaryngol Pol; 2013; 67(1):1-5. PubMed ID: 23374656
[TBL] [Abstract][Full Text] [Related]
23. Identification of Torque Teno Virus/Torque Teno-Like Minivirus in the Cervical Lymph Nodes of Kikuchi-Fujimoto Lymphadenitis Patients (Histiocytic Necrotizing Lymphadenitis): A Possible Key to Idiopathic Disease.
Chong Y; Lee JY; Kang CS; Lee EJ
Biomed Hub; 2020; 5(1):1-5. PubMed ID: 32775328
[TBL] [Abstract][Full Text] [Related]
24. Kikuchi-Fujimoto lymphadenitis.
Onciu M; Medeiros LJ
Adv Anat Pathol; 2003 Jul; 10(4):204-11. PubMed ID: 12826826
[TBL] [Abstract][Full Text] [Related]
25. Skin manifestations of Kikuchi-Fujimoto disease: case report and review.
Yen HR; Lin PY; Chuang WY; Chang ML; Chiu CH
Eur J Pediatr; 2004 Apr; 163(4-5):210-3. PubMed ID: 14986121
[TBL] [Abstract][Full Text] [Related]
26. Pediatric Kikuchi-Fujimoto disease: A clinicopathologic study and the therapeutic effects of hydroxychloroquine.
Lin YC; Huang HH; Nong BR; Liu PY; Chen YY; Huang YF; Chiou YH; Lee HS
J Microbiol Immunol Infect; 2019 Jun; 52(3):395-401. PubMed ID: 29050748
[TBL] [Abstract][Full Text] [Related]
27. A Case of Kikuchi-Fujimoto Disease in a 7-Year-Old African American Patient: A Case Report and Review of Literature.
Kim L; Tatarina-Numlan O; Yin YD; John M; Sundaram R
Am J Case Rep; 2020 Aug; 21():e922784. PubMed ID: 32830793
[TBL] [Abstract][Full Text] [Related]
28. [Kikuchi-Fujimoto disease prior to childhood-systemic lupus erythematosus diagnosis].
Martins SS; Buscatti IM; Freire PS; Cavalcante EG; Sallum AM; Campos LM; Silva CA
Rev Bras Reumatol; 2014; 54(5):400-3. PubMed ID: 25627306
[TBL] [Abstract][Full Text] [Related]
29. Childhood Kikuchi-Fujimoto disease.
Zou CC; Zhao ZY; Liang L
Indian J Pediatr; 2009 Sep; 76(9):959-62. PubMed ID: 19904514
[TBL] [Abstract][Full Text] [Related]
30. Kikuchi-Fujimoto disease: PET/CT assessment of a rare cause of cervical lymphadenopathy.
Tsujikawa T; Tsuchida T; Imamura Y; Kobayashi M; Asahi S; Shimizu K; Tsuji K; Okazawa H; Kimura H
Clin Nucl Med; 2011 Aug; 36(8):661-4. PubMed ID: 21716016
[TBL] [Abstract][Full Text] [Related]
31. Kikuchi-Fujimoto Disease in Children: An Important Diagnostic Consideration for Cervical Lymphadenitis.
Batton E; Alali M; Hageman JR; Parilla M; Yu KOA
Pediatr Ann; 2019 Oct; 48(10):e406-e411. PubMed ID: 31610000
[TBL] [Abstract][Full Text] [Related]
32. Detection of human herpesvirus DNA in Kikuchi-Fujimoto disease and reactive lymphoid hyperplasia.
Hudnall SD; Chen T; Amr S; Young KH; Henry K
Int J Clin Exp Pathol; 2008 Jan; 1(4):362-8. PubMed ID: 18787614
[TBL] [Abstract][Full Text] [Related]
33. Kikuchi-Fujimoto disease is mediated by an aberrant type I interferon response.
Li EY; Xu J; Nelson ND; Teachey DT; Tan K; Romberg N; Behrens E; Pillai V
Mod Pathol; 2022 Apr; 35(4):462-469. PubMed ID: 34952944
[TBL] [Abstract][Full Text] [Related]
34. Kikuchi-Fujimoto disease following vaccination against human papilloma virus infection and Japanese encephalitis.
Watanabe T; Hashidate H; Hirayama Y; Iinuma Y
Eur J Pediatr; 2012 Sep; 171(9):1409-11. PubMed ID: 22476507
[TBL] [Abstract][Full Text] [Related]
35. Kikuchi-Fujimoto Disease Following COVID-19 Vaccination: Experience at a Population-Based Referral Center.
Craig JW; Farinha P; Jiang A; Lytle A; Skinnider B; Slack GW
Am J Clin Pathol; 2023 Aug; 160(2):114-118. PubMed ID: 37526500
[TBL] [Abstract][Full Text] [Related]
36. Paediatric Kikuchi-Fujimoto disease: a benign cause of fever and lymphadenopathy.
Lazzareschi I; Barone G; Ruggiero A; Liotti L; Maurizi P; Larocca LM; Riccardi R
Pediatr Blood Cancer; 2008 Jan; 50(1):119-23. PubMed ID: 16755552
[TBL] [Abstract][Full Text] [Related]
37. Development of Kikuchi-Fujimoto disease after a cervical lymph node metastasis of mucoepidermoid carcinoma: a case report.
Higaki M; Kanda T; Ando T; Tani R; Toratani S
Oral Maxillofac Surg; 2021 Mar; 25(1):133-137. PubMed ID: 32856133
[TBL] [Abstract][Full Text] [Related]
38. An investigation of the viral pathogenesis of Kikuchi-Fujimoto disease. Lack of evidence for Epstein-Barr virus or human herpesvirus type 6 as the causative agents.
Hollingsworth HC; Peiper SC; Weiss LM; Raffeld M; Jaffe ES
Arch Pathol Lab Med; 1994 Feb; 118(2):134-40. PubMed ID: 8311651
[TBL] [Abstract][Full Text] [Related]
39. Kikuchi-Fujimoto disease: evaluation of prognostic factors and analysis of pathologic findings.
Marunaka H; Orita Y; Tachibana T; Miki K; Makino T; Gion Y; Nishizaki K; Yoshino T; Sato Y
Acta Otolaryngol; 2016 Sep; 136(9):944-7. PubMed ID: 27056102
[TBL] [Abstract][Full Text] [Related]
40. Immunopathology of Kikuchi-Fujimoto disease: A reappraisal using novel immunohistochemistry markers.
Sukswai N; Jung HR; Amr SS; Ng SB; Sheikh SS; Lyapichev K; El Hussein S; Loghavi S; Agbay RLMC; Miranda RN; Medeiros LJ; Khoury JD
Histopathology; 2020 Aug; 77(2):262-274. PubMed ID: 31854007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
